SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008294
Filing Date
2024-05-15
Accepted
2024-05-15 16:25:33
Documents
79
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rzlt-20240331x10q.htm   iXBRL 10-Q 1499156
2 EX-4.1 rzlt-20240331xex4d1.htm EX-4.1 114593
3 EX-31.1 rzlt-20240331xex31d1.htm EX-31.1 15326
4 EX-32.1 rzlt-20240331xex32d1.htm EX-32.1 7365
  Complete submission text file 0001558370-24-008294.txt   7748216

Data Files

Seq Description Document Type Size
5 EX-101.SCH rzlt-20240331.xsd EX-101.SCH 54768
6 EX-101.CAL rzlt-20240331_cal.xml EX-101.CAL 39642
7 EX-101.DEF rzlt-20240331_def.xml EX-101.DEF 252794
8 EX-101.LAB rzlt-20240331_lab.xml EX-101.LAB 389465
9 EX-101.PRE rzlt-20240331_pre.xml EX-101.PRE 409717
83 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20240331x10q_htm.xml XML 1417713
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 24951345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)